Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.

Fiche publication

Date publication

octobre 2017

Journal

Oncotarget

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier , Dr MOUNIER Morgane , Dr ROSSI Cédric

Tous les auteurs :
Rossi C, Mounier M, Brice P, Safar V, Nicolas-Virelizier E, Rey P, Stamatoullas-Bastard A, Alcantara M, Chauchet A, Reboursière E, Filliatre L, Perrot A, Garciaz S, Salles G, Coiffier B, Ghesquières H, Casasnovas RO

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29156707

Résumé

Infradiaphragmatic Hodgkin Lymphoma (IDHL) accounts for 3-11% of adult cases of stage I-II Hodgkin Lymphoma and the treatment strategy in IDHL is still heterogeneous. All previous published studies were conducted before the PET-CT era. PET may provide a more accurate evaluation of IDHL stage. The aim of this study was to analyze the clinical and biological characteristics of IDHL patients staged by CT scan or PET-CT in eight French hematology departments and their impact on outcomes in these patients.